I am a
Home I AM A Search Login

Papers of the Week

Papers: 28 May 2022 - 3 Jun 2022

2022 May 27


Long-term open-label safety study of galcanezumab in patients with episodic or chronic cluster headache.


Riesenberg R, Gaul C, Stroud CE, Dong Y, Bangs ME, Wenzel R, Martinez JM, Oakes T M
Cephalalgia. 2022 May 27:3331024221103509.
PMID: 35633025.


CGAR, a Phase 3b open-label study, evaluated the long-term safety of galcanezumab in patients with cluster headache who completed one of two Phase 3 double-blind studies in chronic or episodic cluster headache.